Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Learn the key factors that contribute to a reliable dividend stock. Make informed investment choices for steady income.
20,247 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Bank of America initiates coverage on Salesforce with an Underperform rating and a $160 price target, highlighting un...
A major private markets investor recently exited its position in Paymentus Holdings, shedding a sizable stake in a mo...
Credo Technology faces a pivotal Q4 print as analysts and traders dissect margins, inventory builds, and AI demand si...
As cannabis markets evolve, Green Thumb Industries stands out for its cash generation, branding, and disciplined grow...
Meta Platforms accelerates its MTIA chip program, signaling a high-stakes race with NVIDIA as hyperscalers push for i...
Uber trades lower after peaking earlier in the year, but quarterly earnings rose sharply as the company leans into au...
U.S. stocks rose as markets entered a holiday-shortened week ahead of the Fourth of July. The S&P 500 led gains while...
Super Micro Computer has shed roughly 36% in the past month, trading near the mid-$20s as AI infrastructure spending ...
Evercore ISI launches SpaceX coverage with an Outperform rating and a $230 target, fueling a new wall street spacex b...
An executive chair's sizable stock sale draws attention. This piece explains what the numbers mean, how to read insid...
A boutique investor firm makes a bold healthcare bet by accumulating over 2 million Baxter International shares. The ...